Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38744
CAS Number:
520-85-4
Médroxyprogestérone
Purity:
≥ 98 % (HPLC)
Synonym(s):
17α-hydroxy-6α-méthyl-4-prégnène-3,20-dione, 6α-méthyl-5-prégnène-17α-ol-3,20-dione
Documents
$258.09 /1G
Taille
Request Bulk Quote
Informations sur le produit

Medroxyprogesterone is a synthetic progestin widely utilized in various therapeutic applications, particularly in hormone replacement therapy and contraceptive formulations. This compound mimics the natural hormone progesterone, playing a crucial role in regulating the menstrual cycle and maintaining pregnancy. Its unique properties allow it to effectively manage conditions such as endometriosis, abnormal uterine bleeding, and menopausal symptoms. Medroxyprogesterone is also employed in combination therapies to enhance the efficacy of estrogen in hormone replacement regimens, providing a balanced approach to hormone management.

In addition to its therapeutic uses, Medroxyprogesterone is recognized for its role in reproductive health research, where it aids in studying hormonal influences on fertility and menstrual disorders. Its versatility and effectiveness make it a valuable asset in both clinical and research settings, offering significant benefits over other progestins due to its stability and prolonged action. Researchers and healthcare professionals can rely on Medroxyprogesterone for its proven efficacy and safety profile, making it an essential compound in modern medicine.

Numéro CAS 
520-85-4
Formule moléculaire
C22H32O3
Poids moléculaire 
344.5
Point de fusion 
215 - 220 °C
Rotation optique 
[α] 20 D = 73 - 77 ° (C = 1 dans CHCl 3 )
Informations générales
Numéro CAS 
520-85-4
Formule moléculaire
C22H32O3
Poids moléculaire 
344.5
Point de fusion 
215 - 220 °C
Rotation optique 
[α] 20 D = 73 - 77 ° (C = 1 dans CHCl 3 )
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Medroxyprogesterone is widely utilized in research focused on:

  • Hormonal Contraception: This compound is a key ingredient in various contraceptive methods, providing effective pregnancy prevention by inhibiting ovulation and altering the uterine lining.
  • Menstrual Cycle Regulation: It is commonly prescribed to manage irregular menstrual cycles, helping women achieve more predictable periods and alleviate symptoms associated with hormonal imbalances.
  • Hormone Replacement Therapy (HRT): In postmenopausal women, it is used in combination with estrogen to reduce the risk of endometrial hyperplasia, offering a safer alternative for managing menopausal symptoms.
  • Treatment of Endometriosis: Medroxyprogesterone is effective in treating endometriosis by reducing the growth of endometrial tissue, providing relief from pain and discomfort.
  • Oncology Applications: In certain cases, it is used as part of the treatment regimen for specific types of cancer, such as endometrial cancer, due to its ability to inhibit tumor growth.

Citations